Question 1

What is combined oxidative phosphorylation deficiency 46?

Accepted Answer

Combined oxidative phosphorylation deficiency 46 is a multisystem condition that primarily affects mitochondrial energy production. It is characterized by impaired function in key cellular processes, with decreased liver function and reduced activity of mitochondrial complexes I and IV. The condition is linked to pathogenic variants in the MRPS23 gene and follows an autosomal recessive inheritance pattern, meaning affected individuals inherit two altered copies of the gene. Prevalence estimates are not well established, and the condition appears to affect individuals from early in life.

Question 2

What are the symptoms of combined oxidative phosphorylation deficiency 46?

Accepted Answer

Clinically, individuals with combined oxidative phosphorylation deficiency 46 consistently exhibit decreased liver function and reduced activity of mitochondrial complex I and complex IV, findings that are observed in all documented cases. These manifestations reflect an overall disruption in mitochondrial energy production, which can contribute to various systemic complications over time. Not all individuals experience every possible symptom, and the severity of clinical features varies considerably among affected patients.

Question 3

What causes combined oxidative phosphorylation deficiency 46?

Accepted Answer

The condition is caused by pathogenic variants in the MRPS23 gene, which is important for proper mitochondrial protein synthesis and energy production. As an autosomal recessive disorder, an individual must inherit two altered copies of MRPS23, one from each parent, to develop the condition. This inheritance pattern means that siblings of an affected individual have a 25% chance of being affected, and genetic counseling is recommended to help families understand these implications. Associated genes include MRPS23.

Question 4

How is combined oxidative phosphorylation deficiency 46 inherited?

Accepted Answer

combined oxidative phosphorylation deficiency 46 follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How is combined oxidative phosphorylation deficiency 46 diagnosed?

Accepted Answer

Diagnosis of combined oxidative phosphorylation deficiency 46 is confirmed through molecular genetic testing that identifies pathogenic variants in the MRPS23 gene. In addition to genetic testing, thorough clinical evaluation including assessment of liver function and mitochondrial enzyme activity is essential, as these biochemical findings support the diagnosis. Because the symptoms can overlap with other metabolic disorders, definitive genetic testing is crucial to distinguish this condition from others with similar presentations.

Question 6

Are there treatments for combined oxidative phosphorylation deficiency 46?

Accepted Answer

Currently, management focuses on supportive care and symptom management because there are no approved or foundational therapies specifically indicated for combined oxidative phosphorylation deficiency 46. Treatment is highly individualized and typically involves a multidisciplinary team to address the various complications associated with reduced mitochondrial function. Patients are encouraged to discuss treatment options with their healthcare team, and genetic counseling is recommended to provide further guidance for families.

Question 7

What complications can arise from combined oxidative phosphorylation deficiency 46?

Accepted Answer

Individuals with combined oxidative phosphorylation deficiency 46 may experience various complications due to mitochondrial dysfunction and decreased liver function. These complications can vary widely among patients and may include issues related to energy production and systemic health. It's important for families to work closely with healthcare providers to monitor and manage these potential complications over time.

Question 8

How does combined oxidative phosphorylation deficiency 46 affect daily life?

Accepted Answer

Living with combined oxidative phosphorylation deficiency 46 can present unique challenges. Individuals may need to manage symptoms related to energy levels and liver function, which can impact daily activities. Supportive care and a tailored management plan from a healthcare team can help improve quality of life and address specific needs.

Question 9

What is the prognosis for someone with combined oxidative phosphorylation deficiency 46?

Accepted Answer

The prognosis for combined oxidative phosphorylation deficiency 46 varies significantly among individuals. While some may experience stabilization of symptoms, others could face progressive complications over time. Families are encouraged to discuss the variable course of the condition with healthcare providers to understand what to expect and how to access support resources.

Question 10

What specialists should be involved in the care of someone with combined oxidative phosphorylation deficiency 46?

Accepted Answer

Care for individuals with combined oxidative phosphorylation deficiency 46 often requires a multidisciplinary team approach. Specialists may include geneticists, metabolic disease experts, and liver specialists to address the various aspects of the condition. Collaborating with a team can help ensure comprehensive management of symptoms and complications related to the disease.

Organ System	Phenotype Count	Example Features
Lab test results	2	Decreased activity of mitochondrial complex IV, Decreased activity of mitochondrial complex I

Research Type	Count	% of Total
Laboratory research	18	53%

Kisho

combined oxidative phosphorylation deficiency 46

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

OMIM

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

Recent Publications

combined oxidative phosphorylation deficiency 46

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

OMIM

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is combined oxidative phosphorylation deficiency 46?

What are the symptoms of combined oxidative phosphorylation deficiency 46?

What causes combined oxidative phosphorylation deficiency 46?

How is combined oxidative phosphorylation deficiency 46 inherited?

How is combined oxidative phosphorylation deficiency 46 diagnosed?

Are there treatments for combined oxidative phosphorylation deficiency 46?

What complications can arise from combined oxidative phosphorylation deficiency 46?

How does combined oxidative phosphorylation deficiency 46 affect daily life?

What is the prognosis for someone with combined oxidative phosphorylation deficiency 46?

What specialists should be involved in the care of someone with combined oxidative phosphorylation deficiency 46?

Explore clinical features

Recent Publications